Autoliv, Inc. — 2021 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2021. This is an annual filing; the supplied text does not provide a standalone fourth-quarter income statement. Autoliv is a global supplier of automotive passive-safety products, principally airbags, seatbelts and steering wheels, and reports one operating segment.
Financial performance
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Net sales | $8.230 billion | $7.447 billion | +10.5%; organic growth +7.9% |
| Gross profit / gross margin | $1.511 billion / 18.4% | $1.247 billion / 16.7% | Margin +1.6 percentage points |
| Operating income / margin | $675 million / 8.2% | $382 million / 5.1% | +76.6%; margin +3.1 points |
| Adjusted operating margin | 8.3% | 6.5% | Non-U.S. GAAP measure |
| Net income attributable to controlling interest | $435 million | $187 million | +133% |
| Diluted EPS | $4.96 | $2.14 | +132% |
| Operating cash flow | $754 million | $849 million | Down $95 million |
| Capital expenditures, net | $454 million | $340 million | Up $114 million |
Cash flow less capital expenditures was approximately $300 million in 2021. Management attributed the operating-cash-flow decline mainly to working-capital changes, partly offset by higher net income. The effective tax rate was 28.9%, versus 35.3% in 2020.
Debt, liquidity and capital allocation
- At year-end, cash and cash equivalents were $969 million; total debt was $2.008 billion and net debt was $1.052 billion, down from $1.214 billion in 2020.
- Leverage ratio was 1.2x, compared with 1.7x in 2020; the company targets approximately 1.0x and a range of 0.5x–1.5x. S&P’s long-term rating was BBB with stable outlook.
- The $1.1 billion revolving credit facility was undrawn and matures in July 2023. The filing says significant debt arrangements have no financial covenants.
- Dividends paid were $165 million in 2021. Quarterly dividends, suspended in 2020 amid pandemic uncertainty, were reinstated in the second quarter of 2021. No shares were repurchased in 2021; a new authorization permits up to $1.5 billion or 17 million shares through 2024.
Material changes and operating drivers
- Global light-vehicle production rose 3% to 73.4 million units, well below the 14% growth expected at the start of the year, as semiconductor shortages and supply-chain disruptions constrained production.
- Organic sales grew 7.9%, outperforming global vehicle production by 5.2 percentage points. The company cited higher safety content per vehicle, recent launches and its order book. Airbag-product sales rose 11.5% reported; seatbelt-product sales rose 8.6%.
- Raw-material inflation created an estimated 1.3-percentage-point operating-margin headwind in 2021, with only partial customer recovery. Direct COVID-related costs were about $14 million; government support was about $2 million.
- Headcount declined by about 8,000 year over year, to approximately 60,600. Restructuring provisions, net of reversals, were $8 million in 2021 versus $99 million in 2020; the year-end restructuring reserve was $88 million.
- Research, development and engineering expense, net, increased 4% to $391 million. Gross R&D and engineering expenditures were $594 million, including $203 million reimbursed by customers.
Outlook, risks and unusual items
For 2022, management indicated approximately 9% global vehicle-production growth, 20% organic sales growth, a negative 3% foreign-exchange effect, adjusted operating margin of approximately 9.5%, tax rate of approximately 30%, operating cash flow of approximately $950 million and capital expenditures of approximately 5.5% of sales. These are non-U.S. GAAP outlook measures where specified; the company did not provide reconciliations because certain items could not be reasonably predicted. Management expected semiconductor shortages to continue limiting production recovery.
- Management expected raw-material costs to reduce 2022 operating margin by about 3 percentage points for the full year, with a larger year-over-year impact in the first half and partial customer recoveries mainly in the second half.
- Key risks include vehicle-production volatility, semiconductor and other supply constraints, inflation and freight costs, pricing pressure, customer and supplier concentration, product recalls and liability, litigation, foreign exchange, tax uncertainty, cybersecurity, and execution of restructuring and efficiency programs.
- A U.S. court entered a December 2021 judgment related to a fatal accident involving a seatbelt manufactured by Autoliv: $13.5 million compensatory damages allocated to the company and $100 million punitive damages. Autoliv sought reconsideration and planned to appeal. It accrued $14 million, the low end of its estimated probable-loss range of $14 million–$114 million, excluding punitive damages; insurance coverage for punitive damages was uncertain.
- Product-liability reserves were $144 million at year-end, with $138 million of related insurance receivables. A separate unannounced recall had a $27 million net reserve; a potential loss relating to a ZF inflator recall was estimated at $0–$43 million, with no accrual recorded.
- Autoliv set ambitions for carbon neutrality in its own operations by 2030 and net-zero emissions across its supply chain by 2040. The filing cautions that sustainability targets depend on factors partly outside the company’s control.
Most important facts for investors to verify
- Whether 2022 production, sales and margin assumptions were achieved, particularly given semiconductor availability and the disclosed raw-material cost headwinds.
- The final outcome, potential damages and insurance recovery in the seatbelt litigation, and any material changes to recall reserves or insurance receivables.
- Cash conversion and working-capital trends as capital expenditures and production volumes change.
- Progress on customer cost recovery, productivity initiatives and restructuring, including whether these offset pricing pressure and inflation.
- Debt maturities, leverage and capital returns, including any share repurchases under the 2022–2024 authorization.
- The assumptions behind adjusted measures and outlook, which exclude certain costs and are not U.S. GAAP measures.